Pediatric mast cell sarcoma of temporal bone with novel l799F (2395 C>T) KIT mutation, mimicking histiocytic neoplasm

American Journal of Surgical Pathology

Volumn 37, Issue 3, 2013, Pages 453-458

  Kim, Young S ^a   Wu, Huiqing ^a   Pawlowska, Anna B ^a   Bautista Quach, Marnelli A ^a   Huang, Qin ^a   Gaal, Karl ^a   Chang, Karen L ^b  

^a CITY OF HOPE NATIONAL MEDICAL CENTER   (United States)

^b Kaiser Permanente Southern California ^*  (United States)

Author keywords

histiocytic neoplasm; KIT mutation discovered in mast cell sarcoma; mast cell sarcoma; pediatrics; therapeutic implications

Indexed keywords

ANTINEOPLASTIC AGENT; STEM CELL FACTOR RECEPTOR;

ADOLESCENT; ARTICLE; BONE TUMOR; CASE REPORT; DIFFERENTIAL DIAGNOSIS; FEMALE; GENETICS; HISTIOCYTIC SARCOMA; HUMAN; IMMUNOHISTOCHEMISTRY; MISSENSE MUTATION; MULTIMODALITY CANCER THERAPY; NUCLEOTIDE SEQUENCE; PATHOLOGY; RADIOTHERAPY; SARCOMA; TEMPORAL BONE;

ADOLESCENT; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; BONE NEOPLASMS; COMBINED MODALITY THERAPY; DIAGNOSIS, DIFFERENTIAL; DNA MUTATIONAL ANALYSIS; FEMALE; HISTIOCYTIC SARCOMA; HUMANS; IMMUNOHISTOCHEMISTRY; MAST-CELL SARCOMA; MUTATION, MISSENSE; PROTO-ONCOGENE PROTEINS C-KIT; RADIOTHERAPY; TEMPORAL BONE;

EID: 84873997985     PISSN: 01475185     EISSN: 15320979     Source Type: Journal    
DOI: 10.1097/PAS.0b013e31828446d6     Document Type: Article

References (16)

1. Bugalia A, Abraham A, Balasubramania P, et al. Mast cell sarcoma of the small intestine: a case report. J Clin Pathol. 2011;64: 1035-1037.
2. Kojima M, Nakamura S, Itoh H, et al. Mast cell sarcoma with tissue eosinophilia arising in the ascending colon. Mod Pathol. 1999;12:739-743.
3. Guenther P, Huebner A, Sobottka S, et al. Temporary response of localized intracranial mast cell sarcoma to combination chemotherapy. J Pediatr Hematol Oncol. 2001;23:134-138.
4. Brcic L, Vuletic L, Stepan J, et al. Mast cell sarcoma of the tibia. J Clin Pathol. 2007;60:424-425.
5. Horny H-P, Parwaresch MR, Kaiserling E, et al. Mast cell sarcoma of the larynx. J Clin Pathol. 1986;39:596-602.
6. Auquit-Auckbur I, Lazar C, Deneyve S, et al. Malignant transformation of mastocytoma developed on skin mastocytosis into cutaneous mast cell sarcoma. Am J Surg Pathol. 2012;36: 779-782.
7. Chott A, Guenther P, Huebner A, et al. Morphologic and immunophenotypic properties of neoplastic cells in a case of mast cell sarcoma. Am J Surg Pathol. 2003;27:1013-1019.
8. Ma H, Xu X, Liu W, et al. Successful treatment of mast cell sarcoma of the uterus with imatinib. Int J Hematol. 2011;94:491-494.
9. Horny HP, Akin C, Metcalfe D, et al. Mastocytosis. In: Swerdlow H, Campos E, Harris N, et al, eds. WHO Classification of Tumors of Haematopoietic and Lymphoid Tissue. Lyon, France: WHO PRESS World Health Organization; 2008:54-61.
10. Tran D, Jokinen C, Argenyi Z. Histiocyte-rich pleomorphic mastocytoma: an uncommon variant mimicking juvenile xanthogranuloma and Langerhans cell histiocytosis. J Cutan Pathol. 2009; 36:1215-1220.
11. Heinrich MC, Owzar K, Corless CL, et al. Correlation of kinase genotype and clinical outcome in the North American intergroup phase III trial of imatinib mesylate for treatment of advanced gastrointestinal stromal tumor: CALGB 150105 study by cancer and leukemia group B and southwest oncology group. J Clin Oncol. 2008;26:5360-5367.
12. Pilen SA, Orazi A, Falini B. Myeloid sarcoma. In: Swerdlow H, Campos E, Harris N, et al, eds. WHO Classification of Tumors of Haematopoietic and Lymphoid Tissue. Lyon, France: WHO PRESS World Health Organization; 2008:140-141.
13. Orfao A, Garcia-Montero A, Sanchez L, et al. Recent advances in the understanding of mastocytosis: the role of KIT mutations. Brit J Haematol. 2007;138:12-30.
14. Roskoski R. Structure and regulation of KIT protein-tyrosine kinase-the stem cell factor receptor. Biochem Biophys Res Commun. 2005;338:1307-1315.
15. Longley BJ, Reaguera MJ, Ma Y. Classes of c-KIT activating mutations: proposed mechanisms of action and implications for disease classification and therapy. Leuk Res. 2001;25: 571-576.
16. Bodemer C, Hermine O, Palmerini F, et al. Pediatric mastocytosis is a clonal disease associated with D816V and other activating c-KIT mutations. J Invest Dermatol. 2010;130:804-815.